These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31400926)

  • 1. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
    Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
    Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
    Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
    Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
    Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.
    Rambau PF; Odida M; Wabinga H
    Afr Health Sci; 2008 Dec; 8(4):234-8. PubMed ID: 20589130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review.
    Liu X; Huang L; Liu M; Wang Z
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes.
    Yen HH; Chen PY; Huang RY; Jeng JM; Lai IR
    J Pathol Clin Res; 2024 Jul; 10(4):e12387. PubMed ID: 38860888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition.
    Jungwirth J; Urbanova M; Boot A; Hosek P; Bendova P; Siskova A; Svec J; Kment M; Tumova D; Summerova S; Benes Z; Buchler T; Kohout P; Hucl T; Matej R; Vodickova L; van Wezel T; Vodicka P; Vymetalkova V
    Sci Rep; 2022 Feb; 12(1):2570. PubMed ID: 35173208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
    Alradhi M; Wen S; Safi M; Al-Danakh A; Wang H; Shopit A; Sun M; Fan B; Li X
    Cancer Med; 2023 Feb; 12(4):3931-3951. PubMed ID: 36779496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.
    Darwanto A; Kitazawa R; Maeda S; Kitazawa S
    Cancer Sci; 2003 May; 94(5):442-7. PubMed ID: 12824891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
    Zaleski MP; Chen H; Roy-Chowdhuri S; Patel KP; Luthra R; Routbort MJ; Kamat AM; Gao J; Siefker-Radtke A; Czerniak B; Guo CC
    Am J Clin Pathol; 2022 Aug; 158(2):263-269. PubMed ID: 35467000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine Diagnostics.
    Haefliger S; Marston K; Alborelli I; Stauffer EJ; Gugger M; Jermann PM; Hoeller S; Tornillo L; Terracciano LM; Bihl M; Matter MS
    Pathobiology; 2023; 90(3):166-175. PubMed ID: 36202073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients.
    Cheng B; Xu L; Zhang Y; Yang H; Liu S; Ding S; Zhao H; Sui Y; Wang C; Quan L; Liu J; Liu Y; Wang H; Zheng Z; Wu X; Guo J; Wen Z; Zhang R; Wang F; Liu H; Sun S
    Heliyon; 2024 Apr; 10(7):e29299. PubMed ID: 38623252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the Incidence and Survival Rates of Colorectal Signet-Ring Cell Carcinoma in the South Korean Population: Analysis of the Korea Central Cancer Registry Database.
    Kim JH; Kim H; Kim JW; Kim HM
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of colorectal cancer patients.
    Afanador CH; Palacio KA; Isaza LF; Ahumada E; Ocampo CM; Muñetón CM
    Biomedica; 2022 May; 42(Sp. 1):154-171. PubMed ID: 35866738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
    Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
    Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome.
    Enblad M; Egerszegi PP; Birgisson H; Sjöblom T; Glimelius B; Folkesson J
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
    Nasu H; Nishio S; Park J; Tasaki K; Terada A; Tsuda N; Kawano K; Kojiro-Sanada S; Akiba J; Ushijima K
    Kurume Med J; 2024 May; 69(3.4):237-249. PubMed ID: 38369337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.